Affiliation:
1. SEI «Institute of Postgraduate Education in Health Sphere of the Republic of Tajikistan», Department of therapy and cardio- rheumatology
Abstract
Aim. To present a comprehensive assessment of rheumatic diseases in association with osteoporosis.Material and methods. A retrospective analysis was made of 180 case histories with various RDs, who were under inpatient observation at the Sughd Regional Clinical Hospital for the period 2018-2019 for the frequency of osteoporosis (OP). Densitometry was used to determine the projection mineral density (in g / cm2) in various parts of the skeleton.Results. When asked about a history of fractures, every third respondent (33.3%) answered positively. According to the results of densitometry, osteoporosis in patients with inflammatory RD was diagnosed in 32.2% of patients. At the same time, the indicators differed significantly by nosology, and the frequency of OP correlated with the intake of corticosteroids. Osteoporosis was detected in every third patient with OA according to densitometry data and in 25% of cases in patients with gout. The results of the analysis to assess the absolute risk of major osteoporotic fractures according to FRAX showed high risk in 2 groups.Conclusion. Thus, the nature and frequency of risk factors for osteoporosis in patients with RA and OA have their characteristics. A history of fractures in patients with RA is often associated with long-term use of GCS, and the presence of menopause in women and the presence of cardiometabolic concomitant diseases play an important role in the progression of AP in patients with OA.
Reference8 articles.
1. Zakharov I.S. Biohimicheskie markyory v diagnostike narusheniy remodelirovaniya kostnoy tkani pri osteoporoze [Biochemical markers in the diagnosis of bone remodeling in osteoporosis]. Vestnik Avitsenny - Avicenna Bulletin, 2013, Vol. 57, No. 4, pp. 119-123.
2. Menshikova I.V. Vtorichnyy osteoporoz pri revmaticheskikh zabolevaniyakh [Secondary osteoporosis in rheumatic diseases]. Formatek, 2014, No. 5, pp. 51-59.
3. Nikitinskaya O.A. Priverzhennost lecheniyu osteoporoza: rezultaty retrospektivnogo kogortnogo issledovaniya [Adherence to osteoporosis treatment: results of a retrospective cohort study]. Nauchno – prakticheskogo Revmatologiya - Scientific and Practical Rheumatology, 2019, No. 57 (4), pp. 415-420.
4. Razzokov A.A. Osobennosti techeniya osteoporoza u mnogorozhavshikh zhenshchin s perelomami sheyki bedra i ikh posledstviyami pri postmenopauzal’nom osteoporoze [Features of osteoporosis in pluripara women with cervical Hip fractures and their consequences in postmenopausal osteoporosis]. Vestnik Akademii medicinskikh nauk Tadzhikistana - Bulletin of the academy of medical sciences of Tajikistan, 2019, Vol. 9, No. 4, pp. 403-416.
5. Toroptsova N.V Obzor klinicheskikh rekomendatsii Amerikanskoy kollegii revmatologov (ASR) po profilaktike i lecheniyu glyukokortikoidnogo osteoporoza [Review of the American College of Rheumatology (ACR) clinical guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis]. Nauchno-prakticheskaya revmatologiya - Scientific and Practical Rheumatology, 2018, Vol. 56, No. 2, pp. 144-151.